Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma
Carcinoma, Renal Cell
The outcome of this discussion is summarised here. Guidance for management of these adverse events is provided. Both clinicians and patients should be aware of the potential side-effects of everolimus and understand that these side-effects are manageable with standard care to optimise patient benefit.